Carbocromen

Carbocromen is a vasodilator and antianginal medication. It is used in the treatment of angina pectoris, a condition characterized by chest pain due to reduced blood flow to the heart. Carbocromen works by relaxing and widening blood vessels, thereby improving blood flow to the heart muscle.

Mechanism of Action

Carbocromen acts as a phosphodiesterase inhibitor, which means it blocks the action of an enzyme called phosphodiesterase. This enzyme is responsible for breaking down cyclic adenosine monophosphate (cAMP), a molecule that plays a crucial role in many biological processes, including the relaxation of smooth muscle tissue. By inhibiting phosphodiesterase, Carbocromen increases the levels of cAMP, leading to relaxation and dilation of blood vessels.

Indications

Carbocromen is indicated for the treatment of angina pectoris. It may also be used in the management of other cardiovascular conditions where improved blood flow is beneficial, such as coronary artery disease and peripheral artery disease.

Side Effects

Like all medications, Carbocromen can cause side effects. Common side effects include headache, dizziness, and flushing. Less common side effects may include nausea, vomiting, and palpitations. Severe side effects are rare but can include hypotension (low blood pressure), tachycardia (fast heart rate), and arrhythmia (irregular heart rhythm).

Contraindications

Carbocromen is contraindicated in patients with known hypersensitivity to the drug. It should also be used with caution in patients with severe liver or kidney disease, as these conditions may affect the metabolism and excretion of the drug.

See Also

• Vasodilator
• Angina Pectoris
• Phosphodiesterase Inhibitor
• Coronary Artery Disease
• Peripheral Artery Disease

Carbocromen Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski